+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature



Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature



Journal of Psychopharmacology 24(7): 1121-1125



Tardive dyskinesia (TD) is a devastating adverse effect of long-term antipsychotic drug treatment. Atypical antipsychotics produce less TD, and it has been shown that they may have a therapeutic effect on pre-existing TD. Here, we report a case of olanzapine-induced TD which did not improve after switching to risperidone but improved after the addition of quetiapine to risperidone regimen. We also provide a brief review of the reported cases on TD induced by atypical antipsychotics which improved after switching to another atypical agent. It is unclear whether some atypical antipsychotics are more effective than others in the treatment of TD. Differences in this property and the underlying mechanism require further study.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051914577

Download citation: RISBibTeXText

PMID: 19395427

DOI: 10.1177/0269881109103827


Related references

The emerging role of atypical antipsychotics in the treatment of tardive dyskinesia induced by other atypical antipsychotics. Journal of Clinical Psychiatry 72(7): 1016; Author Reply 1016-7, 2011

Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations. Drugs in Context 3: 212259, 2014

Atypical antipsychotics and tardive dyskinesia. Journal of Managed Care Pharmacy 8(4): 291-292, 2003

Atypical antipsychotics, tardive dyskinesia, and D(2) receptors. American Journal of Psychiatry 163(8): 1449-1450, 2006

Tardive dyskinesia with atypical antipsychotics in youth. Australasian Psychiatry 21(5): 507-508, 2013

Expected incidence of tardive dyskinesia associated with atypical antipsychotics. Journal of Clinical Psychiatry 61(Suppl. 4): 21-26, 2000

Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Annals of Clinical Psychiatry 18(1): 57-62, 2006

Tardive dyskinesia rates with atypical antipsychotics in older adults. Journal of Clinical Psychiatry 65(Suppl. 9): 21-24, 2004

Tardive dyskinesia, glucose and lipids with conventional and atypical antipsychotics. Schizophrenia Research 60(1): 351-352, 2003

Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics. Progress in Neuro-Psychopharmacology & Biological Psychiatry 31(7): 1535-1536, 2007

Use of atypical antipsychotics and risk of hypertension: A case report and review literature. Sage Open Medical Case Reports 7: 2050313x19841825, 2019

Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. Journal of Clinical Psychiatry 65(Suppl. 9): 16-20, 2004

Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies. Cns Drugs 32(2): 135-147, 2018

Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 50(9): 541-547, 2005

The effect of atypical versus typical antipsychotics on tardive dyskinesia: a naturalistic study. European Archives of Psychiatry and Clinical Neuroscience 257(3): 169-172, 2007